- Home
- IACO vs BNTC Comparison
IACO vs BNTC Comparison
Compare IACO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$12.43
Company Overview
Basic Information| Metric | IACO | BNTC |
|---|---|---|
| Founded | N/A | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 434.4M | 454.2M |
| IPO Year | 2026 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IACO | BNTC |
|---|---|---|
| Price | $9.94 | $12.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $27.67 |
| AVG Volume (30 Days) | 24.1K | ★ 74.1K |
| Earning Date | N/A | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.94 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.91 | $9.85 |
| 52 Week High | $9.95 | $16.76 |
Technical Indicators
Market Signals| Indicator | IACO | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 62.08 | 51.88 |
| Support Level | $9.93 | $11.35 |
| Resistance Level | $9.95 | $13.48 |
| Average True Range (ATR) | 0.00 | 0.64 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 75.12 | 55.22 |
Price Performance
Historical Comparison IACO
BNTC
About IACO Idea Acquisition Corp. Class A Ordinary Shares
Idea Acquisition Corp is a blank check company.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.